Correlation Between Codexis and Telix Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Codexis and Telix Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Codexis and Telix Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Codexis and Telix Pharmaceuticals Limited, you can compare the effects of market volatilities on Codexis and Telix Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Codexis with a short position of Telix Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Codexis and Telix Pharmaceuticals.

Diversification Opportunities for Codexis and Telix Pharmaceuticals

0.0

Correlation Coefficient

Codexis  Telix Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between Codexis and Telix is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Codexis and Telix Pharmaceuticals Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telix Pharmaceuticals and Codexis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Codexis are associated (or correlated) with Telix Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telix Pharmaceuticals has no effect on the direction of Codexis i.e., Codexis and Telix Pharmaceuticals go up and down completely randomly.

Pair Corralation between Codexis and Telix Pharmaceuticals

Given the investment horizon of 90 days Codexis is expected to generate 1.83 times more return on investment than Telix Pharmaceuticals. However, Codexis is 1.83 times more volatile than Telix Pharmaceuticals Limited. It trades about 0.2 of its potential returns per unit of risk. Telix Pharmaceuticals Limited is currently generating about 0.08 per unit of risk. If you would invest  310.00  in Codexis on September 26, 2024 and sell it today you would earn a total of  190.00  from holding Codexis or generate 61.29% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	44.44%
Values	Daily Returns

Codexis  vs.  Telix Pharmaceuticals Limited

Codexis

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Codexis are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Codexis unveiled solid returns over the last few months and may actually be approaching a breakup point.

Telix Pharmaceuticals

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Telix Pharmaceuticals Limited are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile essential indicators, Telix Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Codexis and Telix Pharmaceuticals

The main advantage of trading using opposite Codexis and Telix Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Codexis position performs unexpectedly, Telix Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telix Pharmaceuticals will offset losses from the drop in Telix Pharmaceuticals' long position.

The idea behind Codexis and Telix Pharmaceuticals Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.